Bile acid-dependent intestinal immune regulation
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
About This Grant
Project Summary Bile acids (BAs) have emerged as a rich and important source of immunoregulatory metabolites in the intestines. Yet current views of BAs are incomplete. Reductionist studies administering single BAs to cells or mice, while useful for informing basic BA physicochemical properties, engender ‘1 BA = 1 function’ models that have limited relevance to the vastly more complex physiology that underpins BA metabolism and signaling in vivo. Our goals are to quantify intestinal BA pools in mice, understand how and why they change during intestinal inflammation, and map their interactions with host intestinal cells and receptors. Recognizing that intestinal BA pools are formed and dynamically regulated by endocrine-like signaling connections between the liver (where BAs are made), ileum (where most BAs are absorbed) and colonic microbiota (where most BAs are metabolized), we developed an integrated methods set to interrogate the size, complexity, regulation and function of intestinal BA pools in mice. We validated these approaches in mice that lack the ileal BA reuptake transporter, Asbt/Slc10a2, and that harbor robust and predictable differences in BA metabolism. We also established new computational models, calibrated to in vivo datasets, that offer quantitative insights into the independent inputs that hepatic synthesis, ileal absorption and microbial metabolism each contribute to the establishment and maintenance of enterohepatic BA pools. New preliminary data suggest that Crohn’s disease-like ileitis, which arises spontaneously in human Crohn’s disease patients and TnfARE/+ mice, alters BA circulation and metabolism in ways that ultimately produce a smaller and more pro-inflammatory BA pool. We hypothesize that aberrant ileal BA absorption is triggered by cytokine-driven Asbt downregulation in enterocytes prior to overt histopathology and is a distinctive feature of ileitis in mice and humans Once produced, we posit the ileitis-associated BA pool propagates immune dysfunction and ileitis by disturbing the balance of pro- vs. anti-inflammatory NR ligands available to T cells. We test these hypotheses through two inter-related, but not inter-dependent, aims. We expect these studies will have broad and lasting impacts in the field, both by generating fundamental new insights into the regulation of BA homeostasis, and by yielding actionable new paradigms in the understanding and treatment of human Crohn’s disease.
Grant Summary
Bile acid-dependent intestinal immune regulation is a NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases grant providing up to $796K for university, nonprofit, healthcare org. Applications are due 2030-04-30 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $796K
2030-04-30
- 1Confirm your organization is eligible for Bile acid-dependent intestinal immune regulation from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Bile acid-dependent intestinal immune regulation: Frequently Asked Questions
Who is eligible for the Bile acid-dependent intestinal immune regulation?
Bile acid-dependent intestinal immune regulation is offered by NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Bile acid-dependent intestinal immune regulation provide?
Bile acid-dependent intestinal immune regulation provides up to $796K per award from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Bile acid-dependent intestinal immune regulation deadline?
Applications for Bile acid-dependent intestinal immune regulation are due 2030-04-30 (open). Because deadlines can change, verify the date with the funder, NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Bile acid-dependent intestinal immune regulation?
To apply for Bile acid-dependent intestinal immune regulation, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases.